Skip to main content
. 2015 Sep 22;6(39):42008–42018. doi: 10.18632/oncotarget.5788

Figure 1. Baseline ctDNA association with response to treatment and PFS.

Figure 1

Association of baseline ctDNA concentrations with A. and B. response to treatment and C. and D. 6 months PFS. Median with interquartile range is indicated on each data set. Contingency tables with corresponding Fisher's exact test p-value are indicated below each graph. Kaplan-Meier plots of PFS probabilities according to baseline ctDNA concentrations of E. cases treated with targeted therapies (n = 29) and F. immunotherapies (n = 19). Cox regression p-values, Hazard ratio (HR) and confidence intervals are indicated for each plot.